NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Lena Biosciences

Lena Biosciences

Private
Atlanta, GeorgiaHealthcare & Life Scienceshttps://www.lenabio.com/

Last Round

Grant

Aug 1, 2024

Total Funding Raised

$4.86M

Company Overview

Lena Biosciences is a biotechnology company that develops three-dimensional cell culture tools and organ-on-a-chip platforms for drug discovery, predictive toxicology, and personalized medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

microphysiological systemsMPSorgan-on-a-chip3D cell culturepredictive toxicologydrug discoverytoxicity screeningin vitro assayspreclinical researchcell culture scaffoldsynthetic hemoglobincontract researchhuman-mimetic platformstissue engineeringanimal-free testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lena Biosciences Comps

Public and private peers based on sector, stage, and business model.

Lena Biosciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Lena Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 1, 2024
AcceleratorJul 11, 2022
GrantJun 1, 2022
GrantAug 1, 2020
GrantJul 1, 2018
Grant
Jan 1, 2017

Lena Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2018

    $1.8M grant from National Institute of Environmental Health Sciences.

  • May 1, 2016

    $221K grant from National Center for Advancing Translational Sciences

Lena Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lena Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lena Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersAtlanta, Georgia
Employee Range4
Year Founded2008
Last FundingAug 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.